Report Detail
Global Convalescent Plasma Therapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application
- RnM4348663 |
- 20 October, 2021 |
- Global |
- 109 Pages |
- QYResearch |
- Other
Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism.
Market Insights
QY Research has lately published a report titled “Global Convalescent Plasma Therapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application”, with the help of industry-leading research methods, along with observing subtle details and understanding the overall dynamics.
The insights included in this report have been prepared in view of varied aspects that affect the growth. The report elucidates key drivers, trends, prospects, restraining factors, and challenges that players may across in the coming years. With the assistance of this research, players can recognize and capitalize on profitable opportunities. They can further utilize it to make the required advancements in their operations to acquire a competitive advantage over other participants.
The global Convalescent Plasma Therapy market size is projected to reach US$ million by 2027, from US$ million in 2020, at a CAGR of % during 2021-2027.
Segment Scope
An intensive study of key type and application segments has been done in this segmentation section. The authors of the report have provided reliable figures including revenue forecast data by type and application for the period 2016-2027. They have also studied how the segments are gaining or losing growth in various geographies and their respective countries. Thanks to this study, readers can thoroughly grasp the growth pattern and potential of different segments.
Segment by Type
IgM
IgG
IgA
Segment by Application
Prophylaxis
Treatment
Regional Scope
This segment of the report offers a thorough regional study of the global Convalescent Plasma Therapy market. Drivers and restraints for each region are broadly examined in the report. Readers will get familiar with the driving forces and challenges that are specific to the regions. The specialists have identified growth opportunities in key geographical regions and their respective countries to aid players to reinforce their presence. All the regions and their countries in the report are assessed based on the growth rate and revenue according to the consumption for the period 2016-2027. This geographical analysis will help readers to gain in-depth knowledge of the regional growth. The key geographical regions surveyed in this research report involve North America, Europe, Asia Pacific, Central and South America, and Middle East and Africa. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
Key Players
This section has provided an exhaustive analysis of the strategies that the companies are focusing on to stay ahead of other players. The strategies mainly involve research and development, new product developments, and mergers and acquisitions. The researchers have also provided revenue shares of the key companies, company overview, and the latest company developments so as to help players to sustain the cutthroat competition. In this section, the report offers global revenue data of manufacturers for the period 2016-2021. Following is the list of key manufacturers observed in this research study:
Bio Farma
Grifols
Hilton Pharma
Biotest
BPL
LFB
Octapharma
CSL Behring
Takeda Pharmaceutical Company Limited
Orthosera Kft
Frequently Asked Questions
Which application segment captured the leading share in the Convalescent Plasma Therapy market?
How fragmented is the Convalescent Plasma Therapy market?
Which are the key growth drivers in the Convalescent Plasma Therapy market?
Which are the top strategies undertaken by the Convalescent Plasma Therapy market players?
Which technological trends are likely to affect the Convalescent Plasma Therapy market?
What is the expected Convalescent Plasma Therapy market size by 2027?
Which companies are dominating the Convalescent Plasma Therapy market?
Which region is projected to witness the fastest growth in the future?
What factors are restraining the Convalescent Plasma Therapy market growth?
Which are the emerging companies in the Convalescent Plasma Therapy market?
Table of Contents
1 Market Overview of Convalescent Plasma Therapy
- 1.1 Convalescent Plasma Therapy Market Overview
- 1.1.1 Convalescent Plasma Therapy Product Scope
- 1.1.2 Convalescent Plasma Therapy Market Status and Outlook
- 1.2 Global Convalescent Plasma Therapy Market Size Overview by Region 2016 VS 2021 VS 2027
- 1.3 Global Convalescent Plasma Therapy Market Size by Region (2016-2027)
- 1.4 Global Convalescent Plasma Therapy Historic Market Size by Region (2016-2021)
- 1.5 Global Convalescent Plasma Therapy Market Size Forecast by Region (2022-2027)
- 1.6 Key Regions, Convalescent Plasma Therapy Market Size (2016-2027)
- 1.6.1 North America Convalescent Plasma Therapy Market Size (2016-2027)
- 1.6.2 Europe Convalescent Plasma Therapy Market Size (2016-2027)
- 1.6.3 Asia-Pacific Convalescent Plasma Therapy Market Size (2016-2027)
- 1.6.4 Latin America Convalescent Plasma Therapy Market Size (2016-2027)
- 1.6.5 Middle East & Africa Convalescent Plasma Therapy Market Size (2016-2027)
2 Convalescent Plasma Therapy Market Overview by Type
- 2.1 Global Convalescent Plasma Therapy Market Size by Type: 2016 VS 2021 VS 2027
- 2.2 Global Convalescent Plasma Therapy Historic Market Size by Type (2016-2021)
- 2.3 Global Convalescent Plasma Therapy Forecasted Market Size by Type (2022-2027)
- 2.4 IgM
- 2.5 IgG
- 2.6 IgA
3 Convalescent Plasma Therapy Market Overview by Application
- 3.1 Global Convalescent Plasma Therapy Market Size by Application: 2016 VS 2021 VS 2027
- 3.2 Global Convalescent Plasma Therapy Historic Market Size by Application (2016-2021)
- 3.3 Global Convalescent Plasma Therapy Forecasted Market Size by Application (2022-2027)
- 3.4 Prophylaxis
- 3.5 Treatment
4 Convalescent Plasma Therapy Competition Analysis by Players
- 4.1 Global Convalescent Plasma Therapy Market Size by Players (2016-2021)
- 4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Convalescent Plasma Therapy as of 2020)
- 4.3 Date of Key Players Enter into Convalescent Plasma Therapy Market
- 4.4 Global Top Players Convalescent Plasma Therapy Headquarters and Area Served
- 4.5 Key Players Convalescent Plasma Therapy Product Solution and Service
- 4.6 Competitive Status
- 4.6.1 Convalescent Plasma Therapy Market Concentration Rate
- 4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
- 5.1 Bio Farma
- 5.1.1 Bio Farma Profile
- 5.1.2 Bio Farma Main Business
- 5.1.3 Bio Farma Convalescent Plasma Therapy Products, Services and Solutions
- 5.1.4 Bio Farma Convalescent Plasma Therapy Revenue (US$ Million) & (2016-2021)
- 5.1.5 Bio Farma Recent Developments
- 5.2 Grifols
- 5.2.1 Grifols Profile
- 5.2.2 Grifols Main Business
- 5.2.3 Grifols Convalescent Plasma Therapy Products, Services and Solutions
- 5.2.4 Grifols Convalescent Plasma Therapy Revenue (US$ Million) & (2016-2021)
- 5.2.5 Grifols Recent Developments
- 5.3 Hilton Pharma
- 5.3.1 Hilton Pharma Profile
- 5.3.2 Hilton Pharma Main Business
- 5.3.3 Hilton Pharma Convalescent Plasma Therapy Products, Services and Solutions
- 5.3.4 Hilton Pharma Convalescent Plasma Therapy Revenue (US$ Million) & (2016-2021)
- 5.3.5 Biotest Recent Developments
- 5.4 Biotest
- 5.4.1 Biotest Profile
- 5.4.2 Biotest Main Business
- 5.4.3 Biotest Convalescent Plasma Therapy Products, Services and Solutions
- 5.4.4 Biotest Convalescent Plasma Therapy Revenue (US$ Million) & (2016-2021)
- 5.4.5 Biotest Recent Developments
- 5.5 BPL
- 5.5.1 BPL Profile
- 5.5.2 BPL Main Business
- 5.5.3 BPL Convalescent Plasma Therapy Products, Services and Solutions
- 5.5.4 BPL Convalescent Plasma Therapy Revenue (US$ Million) & (2016-2021)
- 5.5.5 BPL Recent Developments
- 5.6 LFB
- 5.6.1 LFB Profile
- 5.6.2 LFB Main Business
- 5.6.3 LFB Convalescent Plasma Therapy Products, Services and Solutions
- 5.6.4 LFB Convalescent Plasma Therapy Revenue (US$ Million) & (2016-2021)
- 5.6.5 LFB Recent Developments
- 5.7 Octapharma
- 5.7.1 Octapharma Profile
- 5.7.2 Octapharma Main Business
- 5.7.3 Octapharma Convalescent Plasma Therapy Products, Services and Solutions
- 5.7.4 Octapharma Convalescent Plasma Therapy Revenue (US$ Million) & (2016-2021)
- 5.7.5 Octapharma Recent Developments
- 5.8 CSL Behring
- 5.8.1 CSL Behring Profile
- 5.8.2 CSL Behring Main Business
- 5.8.3 CSL Behring Convalescent Plasma Therapy Products, Services and Solutions
- 5.8.4 CSL Behring Convalescent Plasma Therapy Revenue (US$ Million) & (2016-2021)
- 5.8.5 CSL Behring Recent Developments
- 5.9 Takeda Pharmaceutical Company Limited
- 5.9.1 Takeda Pharmaceutical Company Limited Profile
- 5.9.2 Takeda Pharmaceutical Company Limited Main Business
- 5.9.3 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Products, Services and Solutions
- 5.9.4 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Revenue (US$ Million) & (2016-2021)
- 5.9.5 Takeda Pharmaceutical Company Limited Recent Developments
- 5.10 Orthosera Kft
- 5.10.1 Orthosera Kft Profile
- 5.10.2 Orthosera Kft Main Business
- 5.10.3 Orthosera Kft Convalescent Plasma Therapy Products, Services and Solutions
- 5.10.4 Orthosera Kft Convalescent Plasma Therapy Revenue (US$ Million) & (2016-2021)
- 5.10.5 Orthosera Kft Recent Developments
6 North America
- 6.1 North America Convalescent Plasma Therapy Market Size by Country (2016-2027)
- 6.2 United States
- 6.3 Canada
7 Europe
- 7.1 Europe Convalescent Plasma Therapy Market Size by Country (2016-2027)
- 7.2 Germany
- 7.3 France
- 7.4 U.K.
- 7.5 Italy
- 7.6 Russia
- 7.7 Nordic
- 7.8 Rest of Europe
8 Asia-Pacific
- 8.1 Asia-Pacific Convalescent Plasma Therapy Market Size by Region (2016-2027)
- 8.2 China
- 8.3 Japan
- 8.4 South Korea
- 8.5 Southeast Asia
- 8.6 India
- 8.7 Australia
- 8.8 Rest of Asia-Pacific
9 Latin America
- 9.1 Latin America Convalescent Plasma Therapy Market Size by Country (2016-2027)
- 9.2 Mexico
- 9.3 Brazil
- 9.4 Rest of Latin America
10 Middle East & Africa
- 10.1 Middle East & Africa Convalescent Plasma Therapy Market Size by Country (2016-2027)
- 10.2 Turkey
- 10.3 Saudi Arabia
- 10.4 UAE
- 10.5 Rest of Middle East & Africa
11 Convalescent Plasma Therapy Market Dynamics
- 11.1 Convalescent Plasma Therapy Industry Trends
- 11.2 Convalescent Plasma Therapy Market Drivers
- 11.3 Convalescent Plasma Therapy Market Challenges
- 11.4 Convalescent Plasma Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Disclaimer
Summary:
Get latest Market Research Reports on Convalescent Plasma Therapy. Industry analysis & Market Report on Convalescent Plasma Therapy is a syndicated market report, published as Global Convalescent Plasma Therapy Market Report, History and Forecast 2016-2027, Breakdown Data by Companies, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of Convalescent Plasma Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
